Kim et al. 2015, tested 119 invasive ductal carcinoma samples and proposed ER as a marker of relapse and metastasis to axillary lymph nodes in invasive breast cancer (Kim et al. 2015), while in our limited sample size, we found no correlation between hormone receptors and the status of disease. The gene discussed is ESR1; the disease is invasive ductal breast carcinoma.